KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Merck (MRK) Gross Profit (2016 - 2025)

Merck (MRK) has disclosed Gross Profit for 17 consecutive years, with $10.8 billion as the latest value for Q4 2025.

  • On a quarterly basis, Gross Profit fell 8.03% to $10.8 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $48.6 billion, a 0.71% decrease, with the full-year FY2025 number at $48.6 billion, down 0.71% from a year prior.
  • Gross Profit was $10.8 billion for Q4 2025 at Merck, down from $13.4 billion in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $13.4 billion in Q3 2025 to a low of $7.4 billion in Q1 2021.
  • A 5-year average of $10.9 billion and a median of $10.9 billion in 2023 define the central range for Gross Profit.
  • Biggest YoY gain for Gross Profit was 855.15% in 2021; the steepest drop was 15.06% in 2021.
  • Merck's Gross Profit stood at $9.6 billion in 2021, then rose by 3.13% to $9.9 billion in 2022, then rose by 7.73% to $10.7 billion in 2023, then increased by 10.06% to $11.8 billion in 2024, then decreased by 8.03% to $10.8 billion in 2025.
  • Per Business Quant, the three most recent readings for MRK's Gross Profit are $10.8 billion (Q4 2025), $13.4 billion (Q3 2025), and $12.2 billion (Q2 2025).